ARTICLE
Auteur(s) : M Bonnet-Duquennoy1,4, H
Abaibou2,4, M Tailhardat1,2,3, K
Lazou1, S Bosset3, B Le varlet1, P
Cleuziat2, R
Kurfürst1
1Laboratoires LVMH Recherche, 185 avenue de Verdun,
45804 St Jean de Braye Cedex, France
2bioMérieux, 5 rue des Berges, 38000 Grenoble,
France
3INSERM U503 and IFR 128, Unite d’Immunologie et
Allergologie Clinique, Centre Hospitalier Lyon-Sud, F-69495
Pierre-Benite Cedex, France
4Authors with equal contribution
accepté le 29 Septembre 2005
Different studies have demonstrated the importance of
transcriptomic analysis (e.g., using DNA microarrays) of different
physiological pathways and various dermatological diseases [1-5].
However, enthusiasm is sometimes moderated by the recent
demonstration of technological caveats in this type of analysis
[6]. Interestingly, most of the microarray studies performed to
date using 5,000 to 20,000 genes identified less than 100
classifying genes. Therefore, low cost, low density transcriptomic
assays that are both quick to perform and sensitive to clinical
compatibility and high diagnostic quality can offer significant
advantages over high density microarrays. Accordingly, we chose an
OLISA™ (OLISA™: OLIgo Sorbent Array) developed by bioMérieux and
which can monitor simultaneously the expression of up to 15
different genes per well using a standard lab 96-well microtiter
plate. Different studies show that OLISA technology is a sensitive,
rapid and quantitative microarray method [7, 8]. The assessment of
messenger RNA expression by qRT-PCR and microarray methods are
based on comparison with internal standard genes, so-called
housekeeping genes because their expression occurs in any tissue
and cell at relatively constant levels. The accurate quantification
of a true reference gene allows the normalisation of differences in
the amount of amplifiable RNA or cDNA in individual samples
obtained from (i) different amounts of starting material, (ii)
varying quality of starting material and (iii) differences in RNA
preparation and cDNA synthesis, since the internal reference gene
is exposed to the same preparation steps as the gene of interest.
However, numerous studies showed that even these genes see their
expression vary in given situations [9, 10]. Consequently, we chose
to identify first in our cellular or tissue models at least one
housekeeping gene as a precondition to initiate such microarray
studies in our laboratory to understand the physiological
characterization of healthy skin. Thus, four likely housekeeping
genes (GAPDH, S40 ribosomal sub-unit, S26 ribosomal sub-unit and
β-2 microglobulin) previously described [10, 11], were selected to
be assessed at the expression level on normal human keratinocytes
with or without treatments. Because of their well known
transcriptional effects on keratinocytes, retinoic acid and
hydrogen peroxide were chosen as reference treatments to verify no
variation of housekeeping gene expression [12-15]. Finally, the
results on S26 ribosomal sub-unit were further confirmed with the
quantitative reference technology (qRT-PCR) on normal human
keratinocytes and on healthy skin.
Materials and methods
Cell culture
Normal human keratinocytes (NHK) were obtained from plastic surgery
of healthy skin. NHK were cultivated in a keratinocyte serum-free
medium (K-SFM Gibco, Paisley, GB) supplemented with 25 μg/ml BPE
and 2.5 ng/ml EGF (K-SFMc) in a humidified atmosphere (5%
CO2, 37 °C).
Cells were treated with hydrogen peroxide 25 μM for 1 hour at 37
°C and replaced for 24 hours in culture media or with retinoic acid
(RA) at 1μM dissolved in culture medium for 24 h.
Skin specimens and tissue preparation
Facial skin was obtained from 10 Caucasian patients undergoing a
surgical facelift. Two types of skin were recovered for the study:
i) sun-exposed pre-auricular skin which was centred by the
preauricular wrinkle. Wrinkles representing the clinical signs of
photo-aged skin were marked with Indian ink before sampling, as
previously described [16]; ii) homolateral post-auricular skin at a
distance from the post-auricular fold. This piece of skin is
covered by hair and corresponds to sun-protected skin.
Epidermis and dermis were isolated after incubation in dispase
buffer (2 MU/ml in complete medium, Roche Diagnostics, Meylan,
France) overnight at 4 °C. After treatment, epidermis was
snap-frozen in liquid nitrogen and stored at – 80 °C.
Nucleic acid extraction and purification
Total RNA extraction was performed with 1 ml of the commercially
available RNA extraction mixture, RNAplus (Q-BIOgene, Illkirch,
France) in accordance with the manufacturer’s instructions. The
concentration of RNA and its purity were estimated by optical
density at 260 nm and 260/280 nm ratio and by electrophoresis
through agarose gels (Sigma Chemical Co, St Louis, USA). The RNA
stock solutions were stored at – 80 °C. Total extracted RNA
was treated with RNase-free RQ1 DNase (Promega Corp, Madison, USA)
at 37 °C for 30 minutes.
Design, synthesis and spotting of probes
All 60-mer probes were optimised based on bioMérieux (Grenoble,
France) specific criteria, chemically synthesized for highly
efficient coupling oligonucleotides (purity > 95%) then spotted
onto a 96-well microtiter plate (OLISA™) at bioMérieux in a circle
format as previously described [8].
Synthesis of labelled cDNA
10 μg of total RNA were retro-transcribed with Superscript II
Reverse-Transcription kit, (Invitrogen Corporation; Carlsbad, USA)
in the presence of dNTP-biotin. cDNA were purified on microcon
filters following the manufacturer’s recommendations (Millipore
Corp., Canton, USA).
Principle of OLISATM technology
Biotin-labelled targets were denatured with 0.2N NaOH for 5
minutes, then hybridised to oligonucleotide probes in the presence
of a hybridisation solution (0.1 M
Na2HPO4/KH2PO4, 0.5M
NaCl, 0.6% Tween 20, 2% PEG 4000, Salmon DNA sperm, pH 7) for one
hour at 37 °C. Wells were washed at room temperature (RT) four
times with 200 μl of the washing buffer (0.1 M
Na2HPO4/KH2PO4,
Tween20, EDTA) in a fully automated washing system. The detection
solution was added to each well and incubated at 25 °C for 15
minutes. The wells were washed a second time as described above. 50
μl of the staining solution BM-purple-Alkaline Phosphatase (Roche,
Basel, Switzerland) were added to each well following incubation at
25 °C for 15 to 60 minutes. If necessary, 4 μl of EDTA (0.5 M)
can be added to each well to stop the reaction process. Hybridised
arrays were then read using Apimager® (bioMérieux,
Grenoble, France), a densitometry reading system and the density
ratio measurement was determined by taking into account the
normalized diameter and background noise. Spots were considered for
analysis if their response was significantly higher than the
background noise plus three standard deviations. Data analysis was
performed using proprietary software (ApiAnalyser™). For in vivo
samples, a uniform scaling factor was applied to each well assuming
that the signal, for each housekeeping gene under special
conditions, should be unchanged for normalizing the data.
Therefore, the signals from genes of interest were normalized per
well using the signal corresponding to the chosen housekeeping gene
then the inter-wells ratios were calculated independently for each
gene.
Reverse transcription and PCR assays
RNA samples (1 μg) were subjected to reverse transcription
with MMLV reverse transcriptase (Invitrogen, Netherlands) and non
specific random hexamer primers (Amersham Pharmacia Biotech, USA)
at 42 °C for 60 minutes.
To amplify and quantify target cDNA of S26 ribosomal sub-unit,
reverse transcribed samples were subjected to PCR amplification on
the LightCycler™ (Roche Diagnostics, Meylan, France) in 20 μl
containing a final concentration of 0.5 μM of each specific primer
(Upstream: 5’CGCAGCAGTCAGGGACAT3’ Downstream:
5’AGCACCCGCAGGTCTAAATC3’), MgCl2, and 2 μl of ready-to-use
LightCycler™ DNA Master SYBR® Green I. The reaction
conditions were initial denaturation at 95 °C for 8 minutes
followed by 40 cycles of denaturation at 95 °C for 15 seconds,
annealing at 60 °C for 10 seconds, and extension at 72 °C for
10 seconds. PCR product specificity was checked with melting curve
procedure. PCR sensitivity, PCR efficiency and target cDNA
quantification were determined with standard curve performed with a
10-fold serial dilution of plasmidic constructions obtained with
the PCR cloning system (Qiagen, Courtaboeuf, France) in accordance
with the manufacturer’s instructions. Quantitative analysis was
performed using the LightCycler™ software using real-time
fluorogenic detection. The log-linear portion of the standard’s
amplification curve was identified and the crossing point was the
intersection of the closest corresponding line through the
log-linear region and the noise band. The standard curve is the
plot of crossing point versus the log of plasmidic copy number. The
standard curve slope represents the overall reaction
efficiency.
Results
Gene expression levels of GAPDH, S40, S26 and β-2microglobulin
genes with OLISA™
To make sure that the expression levels of these four potential
housekeeping genes behave in a similar way over time in a non
treated cell culture, hybridisation signals of their messenger RNA
were measured in a kinetic mode for up to two hours. Thus, Total
RNA was extracted from normal human keratinocyte cells,
retro-transcribed and then hybridised to OLISA™ biochips without
any amplification process as previously reported [10]. Positive
hybridisations were observed through the enzymatic reaction which
generates a precipitated substrate. Thus, the volume of this
substrate is proportional to the degrees of hybridisation between a
probe on the spot and its corresponding target. In order to compute
this volume, the Apimager® reader system extracts, from
the images taken in a grey value, the optical density that is
proportional to the size and the signal of each spot. Therefore,
the Apimager® reader performs semi-quantitative and
quantitative measurements based on the principle of the optical
densitometry measurement (Data not shown). Thus, the resulting grey
levels under non-saturation conditions are considered for further
analysis only if their values are above the background noise value
plus three sigma (sigma stands for standard deviation). Moreover,
these measured grey levels were compared with the others in a
scatter plot approach prior to any kind of cell treatment. As shown
in ( figure 1 ),
a high positive correlation was established when the GAPDH gene is
compared to S26 ribosomal protein (Panel A), S40 ribosomal protein
(Panel B) and β-2 microglobulin (Panel C). Furthermore, alignments
within these scatter plots of dots corresponding to grey level
signals lead to stretching lines with significant correlation
factors ranking from 79 to 94% (table 1( Table
1 )). When cells underwent treatments by either 25 μM
hydrogen peroxide (H2O2) or 10-6 M of
Retinoic Acid (RA), no significant change in the expression levels
of these four genes was observed as shown in ( figure 2 ). Variations
observed, especially on S26 and GAPDH expression after RA
treatment, were not statistically significant. Thus, these
variations observed on the expression levels of these four genes
are due to possible technical fluctuations that probably occur at
the levels of the transcriptase efficacy and the sample loading.
Taken together, these results clearly demonstrate that these four
genes were constantly expressed and not affected by any of the
treatments tested, suggesting their use as housekeeping genes in
our topic studies. Recently, several controversies were reported on
data obtained from the same biological samples on different
commercial microarrays [6, 17]. Therefore, the validation of
results from biochip platforms more often passes by appeal
confirmation from the q-RT-PCR platform. ( Figure 2 ) shows some
variations on the S26 ribosomal protein gene after RA treatment.
Thus, we chose to validate our OLISA results for this gene using q
RT-PCR method.
Table 1 Correlation factors obtained by alignments of
dots from grey levels of the 4 genes
|
S26 ribosomal protein
|
GAPDH
|
S40 ribosomal protein
|
|
S26 ribosomal protein
|
–
|
–
|
–
|
|
GAPDH
|
+ 0.89 s
|
–
|
–
|
|
40S ribosomal protein
|
+ 0.79 s
|
+ 0.94 s
|
–
|
|
β2 microglobulin
|
+ 0.83 s
|
+ 0.88 s
|
+ 0.90 s
|
Messenger RNA levels of S26 gene with q-RT-PCR
First of all, quantitative real time PCR was used to measure the
basal level of the S26 transcript in non treated NHK cells versus
RA treated NHK cells. Thus, this level in 100 ng of total RNA was
4,016,000 ± 750,206 copies and 4,910,750 ± 1,221,660 copies,
respectively for non-treated and RA treated NHK cells. Hence, when
both results were compared, no statistical difference was observed
(p = 0.3). This result suggests that the RA treatment does not
affect the expression of S26 ribosomal protein coding gene in NHK
cells. Thus, this result confirmed that the S26 coding gene could
be used as a good housekeeping gene for our studies on
keratinocytes.
To verify this result on skin, the S26 transcript levels were
measured on both biopsies surgically taken from sun-exposed and
sun-protected skins. Total RNA was extracted from frozen epidermis
obtained from the facial skin of 10 Caucasian patients who
underwent surgical facelift. As we can see in ( figure 3 ), both biopsies
exhibit a similar pattern for the S26 transcript. Taken together,
these results strongly support our hypothesis which stipulates that
the gene coding the 26S ribosomal protein is a good housekeeping
candidate gene to be used in such a study to assess the gene
expression profiling in human skin.
Discussion
Transcriptomic analysis using micro-array technologies provides a
powerful tool for investigating differential gene expression in
pathological and normal skin, for testing responses to cutaneous
stressors, for understanding the physiological process in healthy
skin, such as photo-ageing, pigmentation disorders and for
identifying new active compounds [1-5].
One major key in gene expression studies is the choice of the
right housekeeping gene that allows standardized results. However,
the absence of inter-platform reproducibility of the technology was
reported by several papers, supporting the need for validation of
the data mainly using the reference technology q-RT-PCR [6, 17].
Therefore, the absence of an adequate housekeeping gene leads more
often to discrepancies between different pangenomic commercial
tools. Moreover, the cost of the technology and difficulties of
managing a large amount of data probably explain the second problem
which is the absence of clinical validation of the genes set
emerging from retrospective studies for prospective dermatological
and cosmetic studies. For this, we need a sensitive, reliable and
cost competitive microarray platform for reaching all the gene
expression requirements in a very short time. For these reasons, we
chose OLISA™ as a simple versatile oligonucleotide microarray
(OLISA™: OLIgo Sorbent Array) which is based on a robust
colorimetric method with a single temperature and easily adaptable
on major standard laboratory equipments.
Gene transcription studies using quantitative real time PCR or
microarray platforms should start with the right selection of at
least one appropriate housekeeping gene that is useful for
individual experimental settings and therefore to be used as a
reference gene for further analysis such as standardization
process. Few studies were performed on the validation of
housekeeping genes on skin. We agree with other authors that more
than one housekeeping gene should be used in order to obtain the
most reliable results in gene transcription analysis. We
demonstrated herein that GAPDH, 40S ribosomal sub-unit, S26
ribosomal sub-unit and β-2 microglobulin genes are truly
housekeeping genes in such studies, using either normal human
keratinocytes or skin biopsies. Moreover, our results obtained on
OLISA™ matched those obtained on the qRT-PCR platform for the S26
ribosomal protein coding gene. Our studies of housekeeping genes
validation using OLISA™ seemed to be encouraging for more
exploration to come in gene expression profiling and therefore to
contribute to a significant breakthrough in the cosmetic and
dermatological fields which are working to understand and quantify
all physiological mechanisms that occur within a healthy skin.
Acknowledgements
We warmly thank Dr S. Schnebert, Dr. P. Courtellemont and all
people involved in this project for their constant encouragement,
support and fruitful discussions, A. Bernois and D. Pellé de Queral
for statistical analysis and A. Challon for technical assistance.
References
1 Hamatani T, Daikoku T, Matsumoto H,
Carter MG, Ko MS, Dey SK. Global gene expression
analysis identifies molecular pathways distinguishing blastocyte
dormancy and activation. Proc Natl Acad Sci USA 2004; 13: 10326-31.
2 Kunz M, Ibrahim SM, Koczan D, Scheid S,
Thiesen HJ, Gross G. DNA microarray technology and its
applications in dermatology. Exp Dermatol 2004; 13: 593-606.
3 Sellheyer K, Belbin TJ. DNA microarrays: from
structural genomics to functional genomics. The applications of
gene chips in dermatology and dermato-pathology. J Am Acad Dermatol
2004; 51: 681-92.
4 Urschitz J, Iobst S, Urban Z, Granda C,
Souza KA, Lupp C, Schilling K, Scott I,
Csiszar K, Boyd CD. A serial analysis of gene expression
in sun-damaged human skin. J Invest Dermatol 2002; 119: 3-13.
5 Cole J, Tsou R, Wallace K, Gibran N,
Isik F. Early gene expression profile of human skin to injury
using high-density cDNA microarrays. Wound Repair Regen 2001; 9:
360-70.
6 Tan PK, Downey TJ, Spitznagel Jr. EL,
Xu P, Fu D, Dimitrov DS, Lempicki RA,
Raaka BM, Cam MC. Evaluation of gene expression
measurements from commercial microarray platforms. Nucleic Acids
Res 2003; 19: 5676-84.
7 Cuzin M. DNA chips: a new tool for genetic analysis and
diagnostics. Transfus Clin Biol 2001; 8: 291-6.
8 Perrin A, Duracher D, Perret M,
Cleuziat P, Mandrand B. A combined oligonucleotide and
protein microarray for the co-detection of nucleic acids and
antibodies associated with HIV, HBV and HCV viral infections. Anal
Biochem 2003; 322: 148-55.
9 Thellin O, Zorzi W, Lakaye B, De Borman B,
Coumans B, Hennen G, Grisar T, Igout A,
Heinen E. Housekeeping genes as internal standards: use and
limits. J Biotechnol 1999; 75: 291-5.
10 Schmittgen TD, Zakrajsek BA. Effect of experimental
treatment on housekeeping gene expression: validation by real-time,
quantitative RT-PCR. J Biochem Biophys Methods 2000; 46: 69-81.
11 Vincent S, Marty L, Fort P. S26 ribosomal
protein RNA: an invariant control for gene regulation experiments
in eucaryotic cells and tissues. Nucleic Acids Res 1993; 21:
1498.
12 Mrass P, Rendl M, Mildner M, Gruber F,
Lengauer B, Ballaun C, Eckhart L, Tschachler E.
Retinoic acid increases the expression of p53 and proapoptotic
caspases and sensitizes keratinocytes to apoptosis: a possible
explanation for tumor preventive action of retinoids. Cancer Res
2004; 64: 6542-8.
13 Bernard FX, Pedretti N, Rosdy M,
Deguercy A. Comparison of gene expression profiles in human
keratinocyte mono-layer cultures, reconstituted epidermis and
normal human skin; transcriptional effects of retinoid treatments
in reconstituted human epidermis. Exp Dermatol 2002; 11: 59-74.
14 Kanda N, Watanabe S. 17beta-estradiol inhibits
oxidative stress-induced apoptosis in keratinocytes by promoting
Bcl-2 expression. J Invest Dermatol 2003; 121: 1500-9.
15 Rojkind M, Dominguez-Rosales JA, Nieto N,
Greenwel P. Role of hydrogen peroxide and oxidative stress in
healing responses. Cell Mol Life Sci 2002; 59: 1872-91.
16 Bosset S, Barre P, Bonnet-Duquennoy M,
Kurfurst R, Bonte F, Schnebert S, Levarlet B,
Nicolas JF. Wrinkles – biological and immunological features.
Eur J Dermatol 2002; 12: 247-52.
17 Marshall E. Getting the noise out of gene arrays.
Science 2004; 306: 630-1.
|